CD274 and metastatic neoplasm: found no significant correlation between PD-L1 discordant rates and PD-L1 status of the primary (positive 42%, negative 22%), PD-L1 positivity threshold, origin of the primary, site of metastatic disease, timing of metastasis (synchronous 44%, metachronous 22%), or types of antibody clones used.